Fibrous dysplasia (FD) is a non-neoplastic tumor-like congenital process, manifested as a localized defect in osteoblastic differentiation and maturation, with the replacement of normal bone with large fibrous stroma and islands of immature woven bone. Fibrous dysplasia has a varied radiographic appearance. If asymptomatic, it does not require treatment.
Fibrous dysplasia can affect any bone and can be divided into four subtypes (although there is some overlap):
- monostotic: single bone
- polyostotic: multiple bones
- craniofacial fibrous dysplasia: skull and facial bones alone
- cherubism: mandible and maxilla alone (not true fibrous dysplasia)
Fibrous dysplasia is found predominantly in children and young adults, with ~75% of patients presenting before the age of 30 years (highest incidence between 3 and 15 years). In polyostotic form, patients usually present by 10 years old. There is no recognized gender predilection .
Although fibrous dysplasia is usually sporadic, a number of associations are well recognized:
- McCune-Albright syndrome: in 2-3% of cases with the polyostotic form
- isolated endocrinopathy without the full McCune-Albright syndrome precocious puberty in girls
- Mazabraud syndrome: soft-tissue myxomas (rare); typically multiple intramuscular lesions in the vicinity of most severely affected bone
The condition is often an incidental finding and is usually painless. Alternatively, it may present due to bony expansion or remodeling. Morbidity may arise from compression and displacement of adjacent structures. This is particularly true in craniofacial fibrous dysplasia, where the content of the orbit or cranial nerves may be compressed.
Fibrous dysplasia is due to developmental dysplasia and focal arrest in normal osteoblastic activity secondary to a non-hereditary mutation which results in the presence of all of the components of normal bone with a lack of normal differentiation into their mature structures.
Macroscopically, lesions are intramedullary and well circumscribed with abnormal whitish-grey color.
Microscopically it manifests as large fibrous matrix with scattered curvilinear irregularly shaped trabeculae of immature, inadequately mineralized bone . There is no rimming by osteoblasts differentiating feature from cemento-ossifying fibroma. Cartilaginous islands are present in 10%, differentiating feature from chondrosarcoma.
Monostotic form (involving only one bone)
This is by far the most common and accounts for 70-80% of cases . It is usually asymptomatic until 2-3 decade but can be seen throughout adulthood . After puberty, the disease becomes inactive, and monostotic form does not progress to polyostotic form.
In the remaining 20-30% of cases, multiple bones are involved. As expected this presents earlier, typically in childhood (mean age of 8 years) with two-thirds symptomatic by the age of 10.
- ribs: 28%, most common
- proximal femur: 23%
- craniofacial bones: 10-25%
- often unilateral and monomelic: one limb
- femur: 91%
- tibia: 81%
- pelvis: 78%
- foot: 73%
- skull and facial bones: 50%
- upper extremities
- lumbar spine: 14%
- clavicle: 10%
- cervical spine: 7%
The appearance of fibrous dysplasia is usually smooth and homogenous with endosteal scalloping and cortical thinning . The borders are well defined and the cortex is usually intact but thinned due to the expansive nature of the lesion . Other features include:
- ground-glass matrix
- may be completely lucent (cystic) or sclerotic
- well circumscribed lesions
- no periosteal reaction
- rind sign
Pelvis and ribs
Ribs are the most common site of monostotic fibrous dysplasia. Fibrous dysplasia is the most common cause of a benign expansile lesion of a rib (see rib lesions)
- bubbly cystic lesions
- fusiform enlargement of ribs
- protrusio acetabuli
- may lead to premature fusion of growth plates leading to short stature
- bowing deformities
- shepherd crook deformity of the femoral neck
- discrepant limb length
- Looser zones
- ground-glass opacities: 56%
- homogeneously sclerotic: 23%
- cystic: 21%
- well-defined borders
- expansion of the bone, with intact overlying bone
- endosteal scalloping may be seen
MRI is not particularly useful in differentiating fibrous dysplasia from other entities as there is marked variability in the appearance of the bone lesions, and they can often resemble a tumor or more aggressive lesions.
- T1: heterogeneous signal, usually intermediate
- T2: heterogeneous signal, usually low, but may have regions of higher signal
- T1 C+ (Gd): heterogeneous contrast enhancement
Demonstrates increased tracer uptake on Tc bone scans (lesions remain metabolically active into adulthood).
Treatment and prognosis
Usually, no treatment is required as the bone lesions usually do not progress beyond puberty. If a mass effect is severe, then surgical decompression may be considered. The monostotic form does not transform or progress into the polyostotic form .
Not surprisingly, bone affected by fibrous dysplasia is weaker than normal and thus susceptible to pathological fractures.
Sarcomatous dedifferentiation (osteosarcoma [most common ], fibrosarcoma, malignant fibrous histiocytoma, or rarely chondrosarcoma) is occasionally seen (< 1%) and is more common in the polyostotic form. It should be noted that many reported cases may relate to previous treatment with radiation therapy .
Due to the variability of the appearance of fibrous dysplasia the potential differential is very long but will be significantly influenced by the dominant pattern.
- Paget disease
- mosaic pattern bone histologically
- radiographically may be similar
- different demographics
- neurofibromatosis type I
- osseous lesions are rare
- vertebral column is the primary target
- ribbon ribs
- other features of the disease usually present
- osteofibrous dysplasia
- almost exclusively in tibia with anterior bowing
- lesion begins in cortex
- usually seen in children <10 years
- 80% seen in the tibia
- may appear indistinguishable
- non-ossifying fibroma
- simple bone cyst
- giant cell tumor